Why the study?
Does cilostazol slow cognitive decline in patients with mild cognitive impairment?
Does cilostazol slow cognitive decline in patients with mild cognitive impairment?
This study protocol outlines a trial to evaluate whether cilostazol can prevent cognitive decline in patients with mild cognitive impairment.
No takes yet. Share an insight, caveat, or question.
Cilostazol does not slow MCI-to-dementia conversion; challenges preclinical and observational signals, leaving alternative vascular targets open for testing.
Saitô et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: